Tirzepatide 20mg

Description

Tirzepatide (Dual Incretin Receptor Agonist)

Tirzepatide is a synthetic, 39-amino acid linear polypeptide that functions as a highly specific, dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In molecular biology, it is specifically engineered with a C20 fatty diacid moiety, enabling researchers to study its extended half-life and unique binding kinetics in controlled environments.

In-Vitro Synergistic Receptor Assays

This high-concentration 20mg formulation serves as a premium analytical standard for investigating synergistic incretin signaling pathways. Laboratory protocols utilize Tirzepatide in isolated pancreatic and adipocyte cell cultures to observe dual-receptor cross-talk, amplified cAMP generation, and intracellular signal transduction without the interference of systemic physiological variables.

Important Research Notice: This polypeptide is manufactured strictly for in-vitro testing and academic laboratory research. For inquiries regarding specific dual-agonist assays, receptor binding affinities, or bulk analytical supplies, please contact our laboratory team.